Patentability asks whether you can get a patent. Freedom to operate asks the question the business actually cares about: whether you can sell the product without walking into someone else’s live claim. The two get confused constantly, and the confusion is expensive: a product can be perfectly novel and still infringe, and a team that only searched for novelty finds that out from a cease-and-desist letter.
Real FTO work is brutally specific. It is not "is there art in this area". It is this product element, performing this act, in this territory, against claims that are alive today. A granted patent in a market you never enter is noise; an expiring application in your launch market is the whole analysis. The work multiplies across every element in the bill of materials, every act in the chain (make, use, sell, import, export), and every country on the launch plan. Done by hand, that multiplication is why FTO opinions arrive late, cost heavily, and cover less than the business assumed.
Esgenix runs the multiplication for you and keeps the judgment where it belongs. You describe the product with a spec sheet, a bill of materials, or a plain description, and a scoping session turns it into discrete product elements you can review, merge, and split before anything is searched. Territories and acts are set explicitly. Licensed or bought-in parts go in an exclusion tray so cleared components stop generating false alarms. Where the risk lives in an operating range, dual-range sliders capture the range itself.
From "are we exposed?" to "which element, where, until when, and what do we change?"
Then clearance rounds run per element and, when it matters, per party: a round focused on a specific competitor’s estate. Every hit comes back graded in FTO’s own vocabulary: B for blocking, P for partial overlap, W for watch, C for cleared. Overriding a grade requires a reason, and the reason is recorded. That is exactly what you want to be able to show when someone asks, eighteen months later, why a reference was waved through.
The output is not a pile of links. The risk register holds every flagged claim with its grade and evidence. The clearance map shows per-territory verdicts with the acts and blocking features attached. Charts put risk against time: patent life against your launch year, risk by product feature, risk by value-chain lane. The conversation moves from "are we exposed?" to "which element, where, until when, and what do we change?" All of it lands while the claims of your own pending application are still soft enough to route around the problem.
And it ends the way counsel work should end: in a memo. Drafted from the session, reviewed and approved by you, and written for the decision the business is actually trying to make.
